The World Health Organization (WHO) has recognized several types of Covid-19 vaccines are safe to use. They are known to issue an emergency use listing (EUL). then, what vaccines are recognized by WHO?
EUL itself assesses the quality, safety, and efficacy of the Covid-19 vaccine as well as risk management plans and program suitability such as cold chain requirements, as quoted from the WHO website, Tuesday (21/6/2022).
- Sinopharm Vaccine
WHO awarded the EUL to the Sinopharm vaccine produced by the Beijing Bio-Institute of Biological Products Co Ltd, a subsidiary of China National Biotec Group (CNBG) on May 7, 2021. This vaccine uses an inactivated platform for the SARS-CoV-2 virus.
WHO recommends the Sinopharm vaccine for adults aged 18 years and over in two doses with an injection interval of three to four weeks. The Sinopharm vaccine has 79% efficacy.
- Pfizer/BioNTech Vaccines
WHO granted EUL permission for the Pfizer/BioNTech vaccine on December 31, 2020. This vaccine uses Comirnaty Covid-19 mRNA. This vaccine has 95% efficacy against Covid-19
- Moderna Vaccine
The World Health Organization granted EUL clearance to Moderna Biotech’s Covid-19 vaccine on April 30, 2021. This vaccine uses a modified nucleoside (mRNA) platform. The efficacy of this vaccine reaches 94% against Covid-19
- AstraZeneca Vaccine
WHO assigns EUL to the AstraZeneca vaccine produced by AstraZeneca and SKBio (South Korea) and the Serum Institute of India (India). This permit was granted on February 15, 2021. This vaccine uses a vector virus platform. Both have 63.09% efficacy.
- Johnson & Johnson Vaccine
The World Health Organization awarded the EUL to the Johnson & Johnson Covid-19 vaccine produced by Jassen on March 12, 2021. This vaccine uses a vector virus platform. This is a single-dose vaccine.
- Sinovac Vaccine
WHO awarded the EUL to Sinovac BioNTech’s CoronaVac Covid-19 vaccine in March 2021. This vaccine uses a deactivated viral platform. It is a two-dose vaccine with efficacy reaching 65.3%.
- Covaxin Vaccine
WHO issued the EUL on Bharat Biotech International’s Covaxin vaccine on 3 November 2021. This vaccine uses a deactivated viral platform. Vaccine efficacy reaches 78%.
Those are the seven types of Covid-19 vaccines that have been recognized by the WHO. Unfortunately, the vaccine made in the country, the Nusantara vaccine, has not been directly recognized by WHO.
Furthermore, the Nusantara vaccine has not yet been carried out in phase III clinical trials.